Di Nuzzo Private Wealth, Inc. Gilead Sciences, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $617 Million
- Q1 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 107 shares of GILD stock, worth $11,399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
107
Previous 101
5.94%
Holding current value
$11,399
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GILD
# of Institutions
2,167Shares Held
987MCall Options Held
8.73MPut Options Held
9.44M-
Black Rock Inc. New York, NY121MShares$12.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.3 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.64 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.43 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.17 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $134B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...